https://medicaldialogues.in/news/industry/pharma/astrazeneca-daiichi-sankyo-application-for-datopotamab-deruxtecan-accepted-in-us-for-patients-with-previously-treated-advanced-nonsquamous-non-small-cell-lung-cancer-124678